Ignite Creation Date:
2024-05-06 @ 7:45 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06126146
Status:
COMPLETED
Last Update Posted:
2024-06-03
First Post:
2023-11-07
Brief Title:
An Observational Study to Assess Participant-Reported Real-World Experience of Risankizumab On-body Injector OBI for the Treatment of Crohns Disease in Adult Participants in the United Kingdom UK
Sponsor:
Organization:
AbbVie